1	Lymphogranuloma	Lymphogranuloma	B-NP	NN	O	2	NMOD
2	venereum	venereum	I-NP	NN	O	11	NMOD
3	presenting	present	B-VP	VBG	O	2	NMOD
4	as	as	B-SBAR	IN	O	3	VMOD
5	perianal	perianal	B-NP	JJ	O	6	NMOD
6	ulceration	ulceration	I-NP	NN	O	4	PMOD
7	:	:	O	:	O	2	P
8	an	an	B-NP	DT	O	11	NMOD
9	emerging	emerge	I-NP	VBG	O	11	NMOD
10	clinical	clinical	I-NP	JJ	O	11	NMOD
11	presentation	presentation	I-NP	NN	O	0	ROOT
12	?	?	O	.	O	11	P

1	An	An	B-NP	DT	O	2	NMOD
2	outbreak	outbreak	I-NP	NN	O	10	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	lymphogranuloma	lymphogranuloma	B-NP	NN	O	5	NMOD
5	venereum	venereum	I-NP	NN	O	9	NMOD
6	(	(	O	(	O	8	DEP
7	LGV	LGV	B-NP	NN	O	8	DEP
8	)	)	O	)	O	5	NMOD
9	infection	infection	B-NP	NN	O	3	PMOD
10	has	have	B-VP	VBZ	O	0	ROOT
11	been	be	I-VP	VBN	O	10	VC
12	recognised	recognise	I-VP	VBN	O	11	VC
13	in	in	B-PP	IN	O	12	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	UK	UK	I-NP	NN	O	13	PMOD
16	since	since	B-PP	IN	O	12	VMOD
17	2004	2004	B-NP	CD	O	20	SUB
18	,	,	O	,	O	20	P
19	predominantly	predominantly	B-VP	RB	O	20	AMOD
20	affecting	affect	I-VP	VBG	O	16	PMOD
21	HIV-positive	HIV-positive	B-NP	JJ	O	22	NMOD
22	men	man	I-NP	NNS	O	20	OBJ
23	who	who	B-NP	WP	O	22	NMOD
24	have	have	B-VP	VBP	O	23	SBAR
25	sex	sex	B-NP	NN	O	24	OBJ
26	with	with	B-PP	IN	O	24	VMOD
27	men	man	B-NP	NNS	O	26	PMOD
28	(	(	O	(	O	30	DEP
29	MSM	MSM	B-NP	NN	B-protein	30	DEP
30	)	)	O	)	O	27	NMOD
31	.	.	O	.	O	10	P

1	Patients	Patient	B-NP	NNS	O	3	SUB
2	typically	typically	B-ADVP	RB	O	3	VMOD
3	present	present	B-VP	VBP	O	0	ROOT
4	with	with	B-PP	IN	O	3	VMOD
5	proctitis	proctitis	B-NP	NN	O	6	NMOD
6	symptoms	symptom	I-NP	NNS	O	4	PMOD
7	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	2	NMOD
2	prevalence	prevalence	I-NP	NN	O	15	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	rectal	rectal	B-NP	JJ	O	5	NMOD
5	LGV	LGV	I-NP	NN	O	3	PMOD
6	in	in	B-PP	IN	O	2	NMOD
7	MSM	MSM	B-NP	NN	O	6	PMOD
8	attending	attend	B-VP	VBG	O	7	NMOD
9	sexually	sexually	B-NP	RB	O	10	AMOD
10	transmitted	transmit	I-NP	VBN	O	12	NMOD
11	infection	infection	I-NP	NN	O	12	NMOD
12	clinics	clinic	I-NP	NNS	O	8	OBJ
13	in	in	B-PP	IN	O	12	NMOD
14	London	London	B-NP	NNP	O	13	PMOD
15	is	be	B-VP	VBZ	O	0	ROOT
16	estimated	estimate	I-VP	VBN	O	15	VC
17	at	at	B-PP	IN	O	16	VMOD
18	1	1	B-NP	CD	O	19	NMOD
19	%	%	I-NP	NN	O	17	PMOD
20	.	.	O	.	O	15	P

1	Health	Health	B-NP	NNP	O	4	NMOD
2	Protection	Protection	I-NP	NNP	O	4	NMOD
3	Agency	Agency	I-NP	NNP	O	4	NMOD
4	surveillance	surveillance	I-NP	NN	O	5	SUB
5	has	have	B-VP	VBZ	O	0	ROOT
6	shown	show	I-VP	VBN	O	5	VC
7	a	a	B-NP	DT	O	8	NMOD
8	decrease	decrease	I-NP	NN	O	6	OBJ
9	in	in	B-PP	IN	O	8	NMOD
10	anorectal	anorectal	B-NP	JJ	O	11	NMOD
11	manifestations	manifestation	I-NP	NNS	O	9	PMOD
12	despite	despite	B-PP	IN	O	6	VMOD
13	little	little	B-NP	JJ	O	15	NMOD
14	demographic	demographic	I-NP	JJ	O	15	NMOD
15	change	change	I-NP	NN	O	12	PMOD
16	.	.	O	.	O	5	P

1	Two	Two	B-NP	CD	O	2	NMOD
2	cases	case	I-NP	NNS	O	12	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	HIV-infected	HIV-infected	B-NP	JJ	O	5	NMOD
5	patients	patient	I-NP	NNS	O	3	PMOD
6	presenting	present	B-VP	VBG	O	5	NMOD
7	with	with	B-PP	IN	O	6	VMOD
8	isolated	isolate	B-NP	VBN	O	11	NMOD
9	perianal	perianal	I-NP	JJ	O	11	NMOD
10	ulcer	ulcer	I-NP	NN	O	11	NMOD
11	disease	disease	I-NP	NN	O	7	PMOD
12	are	be	B-VP	VBP	O	0	ROOT
13	reported	report	I-VP	VBN	O	12	VC
14	here	here	B-ADVP	RB	O	13	VMOD
15	.	.	O	.	O	12	P

1	Both	Both	B-NP	DT	O	2	NMOD
2	cases	case	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	confirmed	confirm	I-VP	VBN	O	3	VC
5	to	to	I-VP	TO	O	6	VMOD
6	have	have	I-VP	VB	O	4	VMOD
7	rectal	rectal	B-NP	JJ	O	10	NMOD
8	Chlamydia	Chlamydia	I-NP	NNP	O	10	NMOD
9	trachomatis-specific	trachomatis-specific	I-NP	JJ	O	10	NMOD
10	DNA	DNA	I-NP	NN	O	6	OBJ
11	of	of	B-PP	IN	O	10	NMOD
12	an	an	B-NP	DT	O	15	NMOD
13	LGV	LGV	I-NP	NN	B-protein	15	NMOD
14	associated	associated	I-NP	JJ	I-protein	15	NMOD
15	serovar	serovar	I-NP	NN	I-protein	11	PMOD
16	.	.	O	.	O	3	P

1	As	As	B-SBAR	IN	O	11	VMOD
2	presentations	presentation	B-NP	NNS	O	5	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	LGV	LGV	B-NP	NN	B-protein	3	PMOD
5	diversify	diversify	B-VP	VBP	O	1	SBAR
6	,	,	O	,	O	11	P
7	further	further	B-NP	JJ	O	8	NMOD
8	education	education	I-NP	NN	O	10	NMOD
9	and	and	I-NP	CC	O	10	NMOD
10	surveillance	surveillance	I-NP	NN	O	11	SUB
11	are	be	B-VP	VBP	O	0	ROOT
12	needed	need	I-VP	VBN	O	11	VC
13	in	in	B-SBAR	IN	O	12	VMOD
14	order	order	O	NN	O	13	DEP
15	to	to	B-VP	TO	O	16	VMOD
16	reduce	reduce	I-VP	VB	O	13	SBAR
17	transmission	transmission	B-NP	NN	O	16	OBJ
18	and	and	O	CC	O	16	VMOD
19	prevent	prevent	B-VP	VB	O	16	VMOD
20	long-term	long-term	B-NP	JJ	O	21	NMOD
21	complications	complication	I-NP	NNS	O	19	OBJ
22	.	.	O	.	O	11	P

1	A	A	B-NP	DT	O	3	NMOD
2	strong	strong	I-NP	JJ	O	3	NMOD
3	argument	argument	I-NP	NN	O	5	SUB
4	already	already	B-ADVP	RB	O	5	VMOD
5	exists	exist	B-VP	VBZ	O	25	VMOD
6	for	for	B-PP	IN	O	5	VMOD
7	the	the	B-NP	DT	O	8	NMOD
8	incorporation	incorporation	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	chlamydia	chlamydia	B-NP	NN	O	14	NMOD
11	nucleic	nucleic	I-NP	JJ	O	14	NMOD
12	acid	acid	I-NP	NN	O	14	NMOD
13	amplification	amplification	I-NP	NN	O	14	NMOD
14	tests	test	I-NP	NNS	O	9	PMOD
15	in	in	B-PP	IN	O	5	VMOD
16	the	the	B-NP	DT	O	17	NMOD
17	management	management	I-NP	NN	O	15	PMOD
18	of	of	B-PP	IN	O	17	NMOD
19	MSM	MSM	B-NP	NN	B-protein	18	PMOD
20	with	with	B-PP	IN	O	17	NMOD
21	proctitis	proctitis	B-NP	NN	O	20	PMOD
22	;	;	O	:	O	5	P
23	this	this	B-NP	DT	O	24	NMOD
24	paper	paper	I-NP	NN	O	25	SUB
25	provides	provide	B-VP	VBZ	O	0	ROOT
26	evidence	evidence	B-NP	NN	O	25	OBJ
27	that	that	B-SBAR	IN	O	26	NMOD
28	this	this	B-NP	DT	O	29	SUB
29	should	should	B-VP	MD	O	27	SBAR
30	be	be	I-VP	VB	O	29	VC
31	extended	extend	I-VP	VBN	O	30	VC
32	to	to	B-PP	TO	O	31	VMOD
33	MSM	MSM	B-NP	NN	B-protein	32	PMOD
34	with	with	B-PP	IN	O	31	VMOD
35	perianal	perianal	B-NP	JJ	O	37	NMOD
36	ulcer	ulcer	I-NP	NN	O	37	NMOD
37	disease	disease	I-NP	NN	O	34	PMOD
38	.	.	O	.	O	25	P

